Expression of plasmid-based shRNA against the E1 and nsP1 genes effectively silenced Chikungunya virus replication.
BACKGROUND: Chikungunya virus (CHIKV) is a re-emerging alphavirus that causes chikungunya fever and persistent arthralgia in humans. Currently, there is no effective vaccine or antiviral against CHIKV infection. Therefore, this study evaluates whether RNA interference which targets at viral genomic...
Main Authors: | Shirley Lam, Karen Caiyun Chen, Mary Mah-Lee Ng, Justin Jang Hann Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3466284?pdf=render |
Similar Items
-
Structural and Functional Studies of Chikungunya Virus nsP2
by: Yee Song Law, et al.
Published: (2020-07-01) -
1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors
by: Larisa Ivanova, et al.
Published: (2021-02-01) -
Silencing Human Rb2/p130 with shRNA
by: Eleonora Leucci, et al.
Published: (2007-01-01) -
Characterization of nsP-specific nanobodies targeting Chikungunya and Semliki Forest Virus
by: Andersson, Klara
Published: (2020) -
Validation of shRNA clones for gene silencing in 293FT cells
by: Wang, Wen
Published: (2008)